Idenix Pharma (IDIX) Reports Better-Than Expected Q4 Loss of $0.25
IDIX Hot Sheet
Revenue Growth %: -100.0%Financial Fact:
Loss before income taxes: 11.45M
Today's EPS Names:
TNP, MENT, More
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) reports Q4 loss of $0.25, 5 cents better than the analyst estimate of ($0.30). Revenue for the quarter was $4.3 million, versus the consensus of $2.40 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Infoblox (BLOX) Tops Q3 EPS by 4c; Guides Q4
- Flowers Foods, Inc. (FLO) Reports In-Line Q1 EPS; Adjusts FY12 EPS Growth Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
